ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2870

Overexpression of EZH2 at the microRNA-142 Regulatory Region Contributes to Down-Regulation of microRNA-142-3p/5p in Systemic Lupus Erythematosus

Shu Ding1, Qing Zhang2, Shuangyan Luo2, Lina Tan1, Hai Long3, Ming Zhao3, Yunsheng Liang2 and Qianjin Lu3, 1Department of Dermatology, The Third Xiangya Hospital of Central South University, Changsha, China, 2Department of Dermatology, The Second Xiangya Hospital of Central South University, Changsha, China, 3The Second Xiangya Hospital of Central South University, Changsha, China

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Histone Modification, MicroRNA and systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 15, 2016

Title: Systemic Lupus Erythematosus – Human Etiology and Pathogenesis - Poster II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:

Recently, our group has demonstrated that decreased microRNA-142-3p/5p (miR-142-3p/5p) which contributes to T cell overactivation and B cell hyperstimulation plays an essential role in the pathogenesis of systemic lupus erythematosus (SLE). The aim of this study is to investigate what regulate miR-142-3p/5p expression in SLE.

Methods:  

CD4+ T cells were isolated from SLE patients and healthy controls. Amounts of H3K27me3, EZH2(H3K27 methyltransferases) within the microRNA-142 (miR-142) regulatory region were subsequently analyzed by chromatin immunoprecipitation (ChIP) and real-time PCR in CD4+ T cells from 20 SLE patients and 20 healthy controls. And miR-142-3p/5p expression levels were determined by real-time quantitative polymerase chain reaction.

Results:

By ChIP and real-time PCR experiments, we confirmed increased H3K27me3 enrichment at the miR-142 regulatory region of SLE CD4+ T cells relative to controls. Moreover, H3K27me3 enrichment at the miR-142 regulatory region was negatively correlated with miR-142-3p/5p expression levels in SLE CD4+ T cells. In addition, a striking increase was observed in EZH2 binding at the miR-142 regulatory region in SLE CD4+ T cells compared to healthy controls. We also proved the levels of EZH2 binding were positively correlated with H3K27me3 enrichment at the miR-142 regulatory region, and negatively correlated with miR-142-3p/5p expression levels. Knocking down EZH2 with siRNA in SLE CD4+ T cells led to decreased EZH2 binding and H3K27me3 enrichment at the miR-142 regulatory region, thus increasing the expression of miR-142-3p/5p.

Conclusion:  

Our findings suggest for the first time that increased EZH2 binding up-regulates H3K27me3 enrichment at the miR-142 regulatory region, which inhibits miR-142-3p/5p expression in SLE CD4+ T cells, and contributes to the development of SLE at last. These results can help elucidate the molecular pathogenesis of SLE, and provide a novel way and target for effective SLE therapy.


Disclosure: S. Ding, None; Q. Zhang, None; S. Luo, None; L. Tan, None; H. Long, None; M. Zhao, None; Y. Liang, None; Q. Lu, None.

To cite this abstract in AMA style:

Ding S, Zhang Q, Luo S, Tan L, Long H, Zhao M, Liang Y, Lu Q. Overexpression of EZH2 at the microRNA-142 Regulatory Region Contributes to Down-Regulation of microRNA-142-3p/5p in Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/overexpression-of-ezh2-at-the-microrna-142-regulatory-region-contributes-to-down-regulation-of-microrna-142-3p5p-in-systemic-lupus-erythematosus/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/overexpression-of-ezh2-at-the-microrna-142-regulatory-region-contributes-to-down-regulation-of-microrna-142-3p5p-in-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology